TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Irinotecan to Treat Brain Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Head & Neck Cancer With Chemotherapy and Radiation
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2